Selection and Design of Building Blocks

MolScanner has the ability to independently screen building blocks, which come from a wide range of sources. The active small molecules downstream of these building blocks may come from the latest drug development patents, journals, or small molecules that are in the clinical research stage. These small molecule drugs cover all stages from drug discovery to clinical phase 3 and even market launch.